Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Autolus Therapeutics Q3 EPS $(0.30) Misses $(0.22) Estimate, Sales $21.194M Miss $21.311M Estimate

Author: Benzinga Newsdesk | November 12, 2025 07:02am
Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.22) by 36.99 percent. This is a 3.23 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $21.194 million which missed the analyst consensus estimate of $21.311 million by 0.55 percent.

Posted In: AUTL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist